Position in SRPT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$7,327,373
-$2,531,970 QoQ
Shares Held
336,736
-26.5% QoQ
Ownership
0.319%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 74.91001853083722.ToString("F0")%
Shared 14.8338757958757.ToString("F0")%
None 10.256105673287086.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. SRPT ranks #84 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,327,373 | 336,736 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,859,343 | 458,148 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,556,292 | 651,598 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,746,484 | 803,888 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $37,418,812 | 586,318 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $37,791,385 | 310,810 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,993,552 | 280,195 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $40,352,568 | 255,396 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $29,036,711 | 224,291 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $21,619,699 | 224,201 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $24,641,357 | 203,278 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $20,929,901 | 182,762 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $26,130,498 | 189,585 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $24,992,091 | 192,870 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $20,901,564 | 189,086 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,112,784 | 161,590 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,006,447 | 179,294 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,375,041 | 159,634 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $15,486,423 | 167,457 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,595,201 | 162,017 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $13,144,259 | 176,362 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $32,820,859 | 192,509 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $26,139,078 | 186,136 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $29,266,539 | 182,528 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $18,448,949 | 188,601 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||